Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy [5]

International Journal of Dermatology

Volumn 45, Issue 12, 2006, Pages 1441-1443

  Baskan, Emel Bulbul ^a   Tunali, Şükran ^a   Adim, Saduman Balaban ^a   Kiyici, Murat ^a   Ali, Ridvan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

AGED; ALOPECIA; ANEMIA; CASE REPORT; CHRONIC GASTRITIS; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DUODENUM DISEASE; ELDERLY CARE; FEMALE; GASTROINTESTINAL DISEASE; GRANULOCYTOPENIA; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; HYPERPIGMENTATION; KAPOSI SARCOMA; LETTER; LOW DRUG DOSE; MONOTHERAPY; MOUTH PLAQUE; MULTIPLE CYCLE TREATMENT; MYALGIA; NONHUMAN; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; VIRUS ACTIVATION; VISCERAL METASTASIS;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33845332703     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03142.x     Document Type: Letter

References (10)

1. Welles L, Saville MW, Lietzau J, et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus associated Kaposi's sarcoma. J Clin Oncol 1998; 16: 1112-1121.
2. Tulpule A, Groopman J, Saville MW, et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 2002; 95: 147-154.
3. Chao SC, Lee JY, Tsao CJ. Treatment of classical type Kaposi's sarcoma with paclitaxel. Anticancer Res 2001; 21: 571-573.
4. Engin H, Celik I. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel. Clin Oncol (R Coll Radiol) 2002; 14: 178.
5. Patel N, Salifu M, Sumrani N, et al. Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel. Am J Transplant 2002; 2: 877-879.
6. Parkash SG, Tulpule A, Espina MB, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999; 17: 1876-1883.
7. Stebbing J, Wildfire A, Portsmouth S, et al. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlations. Ann Oncol 2003; 11: 1660-1666.
8. Lim ST, Tupule A, Espina BM, et al. Weekly docetaxel is safe and effective in the treatment of advanced stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2005; 103: 417-421.
9. Cottoni F, Masala MV, Piras MA, et al. Mucosal involvement in classic Kaposi's sarcoma. Br J Dermatol 2003; 148: 1273.
10. Sgadari C, Toschi E, Palladino C, et al. Mechanism of paclitaxel activity in Kaposi's sarcoma. J Immunol 2000; 165: 509-517.